232 related articles for article (PubMed ID: 7201837)
1. Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
Eichelbaum M; Ochs HR; Roberts G; Somogyi A
Arzneimittelforschung; 1982; 32(5):575-8. PubMed ID: 7201837
[TBL] [Abstract][Full Text] [Related]
2. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
[TBL] [Abstract][Full Text] [Related]
3. [Effect of metronidazole on phenazone metabolism].
Staiger C; Wang NS; de Vries J; Weber E
Arzneimittelforschung; 1984; 34(1):89-91. PubMed ID: 6538427
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
Uppal R; Garg SK; Sharma PR; Nair CR; Chaudhury RR
Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928
[TBL] [Abstract][Full Text] [Related]
5. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD
J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of the four antipyrine glucuronides and determination of their urinary excretion pattern in man by a reversed-phase h.p.l.c. assay.
Bässmann H; Böttcher J; Schüppel R; Wray V
Xenobiotica; 1985 Nov; 15(11):941-52. PubMed ID: 4082634
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of antipyrine in epileptic patients.
Rimmer EM; Routledge PA; Tsanaclis LM; Richens A
Br J Clin Pharmacol; 1986 May; 21(5):511-4. PubMed ID: 3718808
[TBL] [Abstract][Full Text] [Related]
9. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
10. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.
Buchanan N; Davis M; Danhof M; Breimer DD
Br J Clin Pharmacol; 1980 Oct; 10(4):363-8. PubMed ID: 7448107
[TBL] [Abstract][Full Text] [Related]
12. [On the pharmacokinetics of phenazone in man (author's transl)].
Brinkmann HJ; Hengstmann JH; Müller F
Arzneimittelforschung; 1977; 27(8):1609-12. PubMed ID: 578756
[TBL] [Abstract][Full Text] [Related]
13. Effect of pregnenolone carbonitrile, promethazine and antipyrine pretreatment on antipyrine metabolite formation in rats.
Shaw PN; Hall ST; Houston JB
Xenobiotica; 1986 Dec; 16(12):1109-16. PubMed ID: 3798958
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens.
De Boever S; Baert K; De Backer P; Croubels S
J Vet Pharmacol Ther; 2005 Dec; 28(6):575-80. PubMed ID: 16343291
[TBL] [Abstract][Full Text] [Related]
15. [Influence of ranitidine on antipyrine metabolism (author's transl)].
Staiger C; Simon B; de Vries J; Kather H; Walter E
Z Gastroenterol; 1980 Dec; 18(12):601-4. PubMed ID: 6116365
[TBL] [Abstract][Full Text] [Related]
16. Antipyrine pharmacokinetics in the tail-suspended rat model.
Brunner LJ; DiPiro JT; Feldman S
J Pharmacol Exp Ther; 1995 Jul; 274(1):345-52. PubMed ID: 7616419
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
18. [Changes in drug elimination under the influence of perazine therapy (author's transl)].
Petruch F; Schüppel R; Breyer U
Arzneimittelforschung; 1976; 26(6):1154-5. PubMed ID: 9113
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M
Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats.
Shaw PN; Tseti J; Warburton S; Adedoyin A; Houston JB
Drug Metab Dispos; 1986; 14(2):271-6. PubMed ID: 2870906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
